Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
Lau, George; Obi, Shuntaro; Zhou, Jian; Tateishi, Ryosuke; Qin, Shukui; Zhao, Haitao; Otsuka, Motoyuki; Ogasawara, Sadahisa; George, Jacob; Chow, Pierce K. H.; Cai, Jianqiang; Shiina, Shuichiro; Kato, Naoya; Yokosuka, Osamu; Oura, Kyoko; Yau, Thomas; Chan, Stephen L.; Kuang, Ming; Ueno, Yoshiyuki; Chen, Minshan; Cheng, Ann-Lii; Cheng, Gregory; Chuang, Wan-Long; Baatarkhuu, Oidov; Bi, Feng; Dan, Yock Young; Gani, Rino A.; Tanaka, Atsushi; Jafri, Wasim; Jia, Ji-Dong; Kao, Jia-Horng; Hasegawa, Kiyoshi; Lau, Patrick; Lee, Jeong Min; Liang, Jun; Liu, Zhenwen; Lu, Yinying; Pan, Hongming; Payawal, Diana A.; Rahman, Salimur; Seong, Jinsil; Shen, Feng; Shiha, Gamal; Song, Tianqiang; Sun, Hui-Chuan; Masaki, Tsutomu; Sirachainan, Ekaphop; Wei, Lai; Yang, Jin Mo; Sallano, Jose D.; Zhang, Yanqiao; Tanwandee, Tawesak; Dokmeci, Akadir; Zheng, Shu-sen; Fan, Jia; Fan, Sheung-Tat; Sarin, Shiv Kumar; Omata, Masao Share Save Share Save Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antiviralsMinami, Tatsuya; Sato, Masaya; Toyoda, Hidenori; Yasuda, Satoshi; Yamada, Tomoharu; Nakatsuka, Takuma; Enooku, Kenichiro; Nakagawa, Hayato; Fujinaga, Hidetaka; Izumiya, Masashi; Tanaka, Yasuo; Otsuka, Motoyuki; Ohki, Takamasa; Arai, Masahiro; Asaoka, Yoshinari; Tanaka, Atsushi; Yasuda, Kiyomi; Miura, Hideaki; Ogata, Itsuro; Kamoshida, Toshiro; Inoue, Kazuaki; Nakagomi, Ryo; Akamatsu, Masatoshi; Mitsui, Hiroshi; Fujie, Hajime; Ogura, Keiji; Uchino, Koji; Yoshida, Hideo; Hanajiri, Kazuyuki; Wada, Tomonori; Kurai, Kiyohiko; Maekawa, Hisato; Kondo, Yuji; Obi, Shuntaro; Teratani, Takuma; Masaki, Naohiko; Nagashima, Kayo; Ishikawa, Takashi; Kato, Naoya; Yotsuyanagi, Hiroshi; Moriya, Kyoji; Kumada, Takashi; Fujishiro, Mitsuhiro; Koike, Kazuhiko; Tateishi, Ryosuke Share Save Share Save Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted TreatmentUeshima, Kazuomi; Komemushi, Atsushi; Aramaki, Takeshi; Iwamoto, Hideki; Obi, Shuntaro; Sato, Yozo; Tanaka, Toshihiro; Matsueda, Kiyoshi; Moriguchi, Michihisa; Saito, Hiroya; Sone, Miyuki; Yamagami, Takuji; Inaba, Yoshitaka; Kudo, Masatoshi; Arai, Yasuaki Share Save The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus InfectionAmano, Hiroyuki; Kanda, Tatsuo; Mochizuki, Hitoshi; Kojima, Yuichiro; Suzuki, Yoji; Hosoda, Kenji; Ashizawa, Hiroshi; Miura, Yuko; Tsunoda, Shotaro; Hirotsu, Yosuke; Ohyama, Hiroshi; Kato, Naoya; Moriyama, Mitsuhiko; Obi, Shuntaro; Omata, Masao Share Save Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with AntiviralsMinami, Tatsuya; Tateishi, Ryosuke; Fujiwara, Naoto; Nakagomi, Ryo; Nakatsuka, Takuma; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Nakagawa, Hayato; Fujinaga, Hidetaka; Izumiya, Masashi; Hanajiri, Kazuyuki; Asaoka, Yoshinari; Kondo, Yuji; Tanaka, Yasuo; Otsuka, Motoyuki; Ohki, Takamasa; Arai, Masahiro; Tanaka, Atsushi; Yasuda, Kiyomi; Miura, Hideaki; Ogata, Itsuro; Kamoshida, Toshiro; Inoue, Kazuaki; Koike, Yukihiro; Akamatsu, Masatoshi; Mitsui, Hiroshi; Fujie, Hajime; Ogura, Keiji; Yoshida, Hideo; Wada, Tomonori; Kurai, Kiyohiko; Maekawa, Hisato; Obi, Shuntaro; Teratani, Takuma; Masaki, Naohiko; Nagashima, Kayo; Ishikawa, Takashi; Kato, Naoya; Moriya, Kyoji; Yotsuyanagi, Hiroshi; Koike, Kazuhiko Share Save Share Save Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular CarcinomaUeshima, Kazuomi; Ogasawara, Sadahisa; Ikeda, Masafumi; Yasui, Yutaka; Terashima, Takeshi; Yamashita, Tatsuya; Obi, Shuntaro; Sato, Shinpei; Aikata, Hiroshi; Ohmura, Takumi; Kuroda, Hidekatsu; Ohki, Takamasa; Nagashima, Kengo; Ooka, Yoshihiko; Takita, Masahiro; Kurosaki, Masayuki; Chayama, Kazuaki; Kaneko, Shuichi; Izumi, Namiki; Kato, Naoya; Kudo, Masatoshi; Omata, Masao Share Save Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS TrialKudo, Masatoshi; Ueshima, Kazuomi; Chiba, Yasutaka; Ogasawara, Sadahisa; Obi, Shuntaro; Izumi, Namiki; Aikata, Hiroshi; Nagano, Hiroaki; Hatano, Etsuro; Sasaki, Yutaka; Hino, Keisuke; Kumada, Takashi; Yamamoto, Kazuhide; Imai, Yasuharu; Iwadou, Shouta; Ogawa, Chikara; Okusaka, Takuji; Kanai, Fumihiko; Arai, Yasuaki Share Save The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world settingObi, Shuntaro; Sato, Takahisa; Sato, Shinpei; Kanda, Miho; Tokudome, Yuta; Kojima, Yuichiro; Suzuki, Yoji; Hosoda, Kenji; Kawai, Toshihiro; Kondo, Yuji; Isomura, Yoshihiro; Ohyama, Hiroshi; Nakagomi, Keiko; Ashizawa, Hiroshi; Miura, Yuko; Amano, Hiroyuki; Mochizuki, Hitoshi; Omata, Masao Share Save Prediction of the very early occurrence of HCC right after DAA therapy for HCV infectionOoka, Yoshihiko; Miho, Kanda; Shuntaro, Obi; Nakamura, Masato; Ogasawara, Sadahisa; Suzuki, Eiichiro; Yasui, Shin; Chiba, Tetsuhiro; Arai, Makoto; Kanda, Tatsuo; Maruyama, Hitoshi; Yokosuka, Osamu; Kato, Naoya; Mochizuki, Hitoshi; Omata, Masao Share Save Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trialKudo, Masatoshi; Ueshima, Kazuomi; Yokosuka, Osamu; Ogasawara, Sadahisa; Obi, Shuntaro; Izumi, Namiki; Aikata, Hiroshi; Nagano, Hiroaki; Hatano, Etsuro; Sasaki, Yutaka; Hino, Keisuke; Kumada, Takashi; Yamamoto, Kazuhide; Imai, Yasuharu; Iwadou, Shouta; Ogawa, Chikara; Okusaka, Takuji; Kanai, Fumihiko; Akazawa, Kohei; Yoshimura, Ken-ichi; Johnson, Philip; Arai, Yasuaki Share Save Multicenter, randomized, controlled trial of S-1 monotherapy versus S-1 and interferon- combination therapy for hepatocellular carcinoma with extrahepatic metastasesNagano, Hiroaki; Obi, Shuntaro; Hatano, Etsuro; Kaneko, Shuichi; Kanai, Fumihiko; Omata, Masao; Tsuji, Akihito; Itamoto, Toshiyuki; Yamamoto, Kazuhide; Tanaka, Masatoshi; Kubo, Shoji; Hirata, Koichi; Nakamura, Hideji; Tomimaru, Yoshito; Yamanaka, Takeharu; Kojima, Shinsuke; Monden, Morito Share Save Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II StudyKudo, Masatoshi; Kang, Yoon-Koo; Park, Joong-Won; Qin, Shukui; Inaba, Yoshitaka; Assenat, Eric; Umeyama, Yoshiko; Lechuga, Maria Jose; Valota, Olga; Fujii, Yosuke; Martini, Jean-Francois; Williams, J. Andrew; Obi, Shuntaro Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}